-- Days : -- HRS : -- MIN : -- SEC

Register Now →

Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

|Articles|July 5, 2018

Improving Provider and Patient Acceptance of Biosimilars in Treating Cancer

https://www.pharmacytimes.org/on-demand/biosimilars-in-treating-cancer

https://www.pharmacytimes.org/on-demand/biosimilars-in-treating-cancer

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Blue FDA approved stamp | Image credit: Surendra-stock.adobe.com

FDA Approves Enlicitide, First Oral PCSK9 for High Cholesterol

ByLaura Joszt, MA

July 16th 2026

Remote patient monitoring | Image credit: AndSus - stock.adobe.com

Remote Monitoring Captured Between-Visit Symptom Swings in Myasthenia Gravis

BySkylar Jeremias

July 15th 2026

Insulin cost - Pixel-Shot - stock.adobe.com.jpeg

FTC Reaches Settlement With CVS Caremark to Curb Insulin Rebate Practices, Cut Patient Costs

ByGiuliana Grossi

July 15th 2026

Hospital emergency room sign | Image credit: Spiroview Inc - stock.adobe.com

Innovation Is Outpacing Reimbursement, Health System Execs Warn

ByLaura Joszt, MA

July 15th 2026

Kerry Rogers, MD, Talks BTK Inhibitor Sequencing, Cost, Access in CLL

ByMaggie L. Shaw,Kerry Rogers, MD

July 15th 2026

Trending on AJMC

FDA Approves Enlicitide, First Oral PCSK9 for High Cholesterol

FDA Approves Gedatolisib for HR+/HER2- Advanced Breast Cancer

MS Likely Unfolds Along a Continuum Years Before First Symptoms

Medicaid Fraud Crackdown Intensifies, But Is It Solving the Right Problem?

FTC Reaches Settlement With CVS Caremark to Curb Insulin Rebate Practices, Cut Patient Costs